CureDuchenne Ventures 2020 Pitch Contest Submission Deadline: July 13, 2020!

Rewarding Rare Approaches to Treat Duchenne Muscular Dystrophy

About the Contest:

  • Open to colleges, universities, biotech companies and pharma companies in the United States with researchers at all career stages
  • Focusing on new Duchenne therapeutics or therapeutic targets, or technology platforms that can help overcome current limitations of Duchenne therapies in development
  • Finalists will have opportunity to pitch their idea to a panel of esteemed judges from the drug development and venture capital communities
  • Email us at Pitch@CureDuchenne.org if you have any questions

The Winning Details:

  • 2 Winners each receiving no-strings attached award of $25,000 by check made out to the winning college, university, or company
  • Access to a wide array of experts in Duchenne drug discovery
  • Ongoing mentoring from CureDuchenne lead scientists Mike Kelly, PhD & Lianna Orlando, PhD

 

 
CureDuchenne Ventures 2020 Pitch Contest
Submission Deadline: July 13, 2020! Two winners each receiving $25,000! For entry details, Official Rules and to meet the judges, please visit: Pitch Contest

 

Image
CureDuchenne Ventures 2020 Pitch Contest
Did you find the content you were looking for?
Please rate how easy it was to navigate the NINDS website

This site is protected by reCAPTCHA and the Google Privacy Policyand Terms of Serviceapply.